# Fn14_Role_In_ER_BC

## Purpose
Investigate the role of Fn14 in ER+ breast cancer and evaluate the usefulness of Fn14 to predict response to adjuvant tamoxifen monotherapy

# Results

## SCAN-B
- [Fn14 mRNA tertiles by ER and HR status](outputs/markdown/Fn14_HR_Barplot.md)
- [Fn14 mRNA expression in ER+ Patients by clinicopathological factors](outputs/markdown/Fn14_ER_Pos_Clin_Path.md)
- [Fn14 mRNA expression in PR+ Patients by clinicopathological factors](outputs/markdown/Fn14_PR_Pos_Clin_Path.md)
- [Fn14 mRNA expression in HR+ Patients by clinicopathological factors](outputs/markdown/Fn14_HR_Pos_Clin_Path.md)
- [Fn14 vs ESR1 mRNA correlation in HR+/HER2- patients treated with endocrine monotherapy](outputs/markdown/Fn14_ESR1_Scatter.md)

## BC2116
- [DMFS Survival analysis of ER, PR, or HR positive patients by Fn14 expression tertiles](outputs/markdown/DMFS_Survival_Analysis.md)
- [DFS Survival analysis of ER, PR, or HR positive patients by Fn14 expression tertiles](outputs/markdown/DFS_Survival_Analysis.md)
- [DSS Survival analysis of ER, PR, or HR positive patients by Fn14 expression tertiles](outputs/markdown/DSS_Survival_Analysis.md)